Whitepapers
Gene Therapies for Ultra-Rare Diseases: New Partnerships and Business Models
Whitepaper
Feb 26, 2025
Oncology Outlook for 2025
Whitepaper
Jan 27, 2025
Recommendations for Managing Challenges in Using SEE in HTA Submissions
Whitepaper
Jan 8, 2025
China at the Crossroads in Biopharma Innovation: Exportation or Leadership
Whitepaper
Dec 24, 2024
The Cellution to Autoimmunity? The promise and perils of CAR-T
Whitepaper
Dec 6, 2024
Navigating Real World Evidence Requirements
Whitepaper
Dec 2, 2024
NICE’s Proportional Approach to Technology Appraisals
Whitepaper
Oct 31, 2024
Long Follow-Up in Short Supply
Whitepaper
Aug 5, 2024
Potential Impact of the IRA on the Generic Drug Market
Will the Inflation Reduction Act transform the generic drug market and disrupt cost savings? Our white paper explores the potential impact of the IRA on generics. Learn how CMS drug price negotiations, revenue shifts, and market access challenges could reshape the landscape.
Whitepaper
Jul 2, 2024
Patient Journey Empowerment: Realizing the potential for patients and your brand
Whitepaper
Dec 11, 2023
Competitive Planning and Response: Where to focus for sustained success
Whitepaper
Nov 22, 2023
Penetrating the CNS – Strategic Implications of an Increasingly Flexible FDA
Whitepaper
Nov 21, 2023